PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Tranexamic acid - Hereditary angiodema
PAD Profile : Tranexamic acid - Hereditary angiodema
Brand Names Include :
Cyklokapron
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- C1-Esterase inhibitor
- Icatibant acetate
- Avoralstat
- Ecallantide
- Berotralstat
- Lanadelumab
- Conestat alfa
Other Indications
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
07 August 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
02. Cardiovascular System
02.11.00. Antifibrinolytic drugs and haemostatics